Open Access Open Access  Restricted Access Subscription Access

Alpha-Fold 3: Revolutionizing Drug Design, Protein Stability, Allostery, and Ai-Driven Therapeutics

Sumaiya P S, Sweety George, Thamanna R P, Manesh D

Abstract


AlphaFold, an AI-driven protein structure prediction system developed by DeepMind, has revolutionized structural biology by achieving remarkable accuracy in protein modeling. By leveraging deep learning techniques, AlphaFold provides high-resolution three-dimensional protein structures, surpassing traditional experimental methods in speed and efficiency. Its applications span drug discovery, cancer research, genomics, and bioengineering, aiding in mutation impact analysis, molecular simulations, and personalized medicine. Despite its success, AlphaFold faces challenges in modeling intrinsically disordered proteins, predicting allosteric mechanisms, and simulating protein dynamics. Future advancements in AI-driven structural biology, molecular modeling, and open-source collaboration will further expand its impact in biomedical research and therapeutic innovations. This study explores the methodologies, applications, and future prospects of AlphaFold, highlighting its transformative role in computational biology

Full Text:

PDF

References


Gerasimavicius, L., Liu, X., & Marsh, J. A. (2020). Identification of pathogenic missense mutations using protein stability predictors. Scientific Reports, 10, 15387. https://doi.org/10.1038/s41598-020-72404-

Angeli, D., Salvi, S., & Tedaldi, G. (2020). Genetic predisposition to breast and ovarian cancers: How many and which genes to test? International Journal of Molecular Sciences, 21, 1128. https://doi.org/10.3390/ijms21031128

Buel, G. R., & Walters, K. J. (2022). Can AlphaFold2 predict the impact of missense mutations on structure? Nature Structural & Molecular Biology, 29, 1–2. https://doi.org/10.1038/s41594-021-00714-2

Tian, J., Smith, G., Guo, H., Liu, B., Pan, Z., Wang, Z., Xiong, S., & Fang, R. (2021). Modular machine learning for Alzheimer's disease classification from retinal vasculature. Scientific Reports, 11, 1–11.

Tonkens, R. (2009). A challenge for machine ethics. Minds and Machines, 19(4).

Wiemken, T. L., & Kelley, R. R. (2020). Machine learning in epidemiology and health outcomes research. Annual Review of Public Health, 41, 21–36.

Yanguas-Gil, A., Mane, A., Elam, J. W., Wang, F., Severa, W., Daram, A. R., & Kudithipudi, D. (2019). The insect brain as a model system for low power electronics and edge processing applications. In Proceedings of the 2019 IEEE Space Computing Conference (SCC) (pp. 60–66). IEEE.

Yang, F., Zhang, Q., Ji, X., Zhang, Y., Li, W., Peng, S., & Xue, F. (2022). Machine learning applications in drug repurposing. Interdisciplinary Sciences: Computational Life Sciences, 14, 15–21. https://doi.org/10.1007/s12539-021-00487-8

Khan, B., Fatima, H., Qureshi, A., Kumar, S., Hanan, A., Hussain, J., & Abdullah, S. (2023). Drawbacks of Artificial Intelligence and their potential solutions in the healthcare sector. Biomedical Materials and Devices, 1, 731–738.

Tian, J., Smith, G., Guo, H., Liu, B., Pan, Z., Wang, Z., Xiong, S., & Fang, R. (2021). Modular machine learning for Alzheimer's disease classification from retinal vasculature. Scientific Reports, 11, 1–11.


Refbacks

  • There are currently no refbacks.